Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.527ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.527ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.98.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.98.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.34.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.34.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.124.1.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.124.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCBENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.519ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.519ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.514ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.514ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used